Home Cart Sign in  
Chemical Structure| 945721-28-8 Chemical Structure| 945721-28-8

Structure of Daratumumab
CAS No.: 945721-28-8

Chemical Structure| 945721-28-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Daratumumab is a humanized IgG1 monoclonal antibody that depletes B cells by binding to the CD38 antigen. Daratumumab has potential for multiple myeloma research.

Synonyms: Anti-Human CD38, Human Antibody

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Daratumumab

CAS No. :945721-28-8
M.W : 145.26 kDa
SMILES Code : NONE
Synonyms :
Anti-Human CD38, Human Antibody
MDL No. :N/A

Safety of Daratumumab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02116569 Multiple Myeloma PHASE1 COMPLETED 2025-09-15 Nagoya, Japan|Tokyo, Japan
NCT05913596 Antibody-mediated Rejection|Ki... More >>dney Tranplant Less << RECRUITING 2024-08-30 79# Qingchun Road, Hangzhou, Z... More >>hejiang, 310003, China Less <<
NCT02852837 Multiple Myeloma PHASE1 COMPLETED 2019-12-13 Beijing, China|Hangzhou, China... More >>|Shanghai, China|Suzhou, China|Tianjin, China Less <<
NCT03475628 Multiple Myeloma PHASE2 UNKNOWN 2020-02-20 General Hospital of Athens "Al... More >>exandra", Athens, Attica, 11528, Greece Less <<
NCT04230031 Multiple Myeloma PHASE2 WITHDRAWN 2025-01-27 Levine Cancer Institute, Charl... More >>otte, North Carolina, 28204, United States Less <<
NCT03207542 Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Less << PHASE2 WITHDRAWN 2025-07-21 -
NCT05054478 Plasma Cell Leukemia PHASE2 NOT_YET_RECRUITING 2025-02-28 -
NCT05832216 Aplastic Anemia|Platelet Trans... More >>fusion Refractoriness Less << PHASE1 COMPLETED 2024-12-01 Regenerative Medicine Center, ... More >>Tianjin, Tianjin, China Less <<
NCT03697629 Multiple Myeloma in Relapse PHASE2 COMPLETED 2021-12-20 Kingston Health Sciences Centr... More >>e, Kingston, Ontario, K7L 2V7, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|H?pital Maisonneuve-Rosemont, Montréal, Quebec, H1T 2M4, Canada|McGill University Health Centre, Montréal, Quebec, H4A 3J1, Canada|H?pital de l'Enfant-Jésus, Québec City, Quebec, G1J 1Z4, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, S7N 4H4, Canada Less <<
NCT04088903 Allosensitization|Heart Transp... More >>lant Failure and Rejection Less << PHASE1 WITHDRAWN 2023-04-01 -
NCT04121260 Multiple Myeloma PHASE1 COMPLETED 2023-10-13 Peking University Third Hospit... More >>al, Beijing, 100191, China|The Third Xiangya Hospital, Central South University, Changsha, 410013, China|Nanfang Hospital, Guangzhou, 510515, China|Zhongda Hospital,Southeast University, Nanjing, 210009, China|Institute of Hematology & Blood Diseases Hospital, Tianjin, 300320, China Less <<
NCT03768960 Multiple Myeloma PHASE4 COMPLETED 2022-07-16 Avron Hospitals Pvt. Ltd, Ahme... More >>dabad, 380013, India|M S Ramaiah Medical College and Hospital, Bengaluru, 560054, India|Sparsh Hospitals & Critical Care (Pvt) Ltd, Bhubaneshwar, 751007, India|Apollo Hospitals, Bhubaneswar, 751005, India|Post Graduate Institute of Medical Education And Research PGIMER, Chandigarh, 160012, India|Apollo Hospitals, Hyderabad, 500033, India|Basavatarakam Indo-American Hospital, Hyderabad, 500034, India|Cytecare Hospitals Pvt. Ltd, Karnataka, 560064, India|Tata Medical Center, Kolkata, 700156, India|Shatabdi Super Speciality Hospital, Mumbai Naka, 422005, India|Kingsway Hospital, Nagpur, 440001, India|Apex Wellness Hospital, Nashik, 422009, India|All India Institute of Medical Sciences, New Delhi, 110029, India|Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 605008, India|Deenanath Mangeshkar Hospital and Research Centre, Pune, 411004, India|Noble Hospital Pvt Ltd, Pune, 411013, India Less <<
NCT03095118 Membranoproliferative Glomerul... More >>onephritis Less << PHASE2 COMPLETED 2020-05-12 Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less <<
NCT03035357 Malignant Neoplasms of Male Ge... More >>nital Organs|Prostate Cancer Less << PHASE2 WITHDRAWN 2019-03-01 -
NCT02477891 Multiple Myeloma APPROVED_FOR_MARKETING - Phoenix, Arizona, United State... More >>s|Little Rock, Arkansas, United States|Duarte, California, United States|Fountain Valley, California, United States|Gilroy, California, United States|Greenbrae, California, United States|Los Angeles, California, United States|West Hollywood, California, United States|Denver, Colorado, United States|New Haven, Connecticut, United States|Jacksonville, Florida, United States|Ocala, Florida, United States|West Palm Beach, Florida, United States|Atlanta, Georgia, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Indianapolis, Indiana, United States|Iowa City, Iowa, United States|Topeka, Kansas, United States|Louisville, Kentucky, United States|Baltimore, Maryland, United States|Bethesda, Maryland, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Saint Louis, Missouri, United States|Great Falls, Montana, United States|Omaha, Nebraska, United States|Flemington, New Jersey, United States|Hackensack, New Jersey, United States|New Brunswick, New Jersey, United States|Buffalo, New York, United States|New York, New York, United States|Chapel Hill, North Carolina, United States|Charlotte, North Carolina, United States|Corvallis, Oregon, United States|Hershey, Pennsylvania, United States|Charleston, South Carolina, United States|Greenville, South Carolina, United States|Dallas, Texas, United States|Houston, Texas, United States|Fairfax, Virginia, United States|Barretos, Brazil|Joao Pessoa, Brazil|Porto Alegre, Brazil|Rio De Janeiro, Brazil|Salvador, Brazil|Sao Paulo, Brazil|Kobe-City, Japan|Moscow, Russian Federation|Novosibirsk, Russian Federation|Saint-Petersburg, Russian Federation|Samara, Russian Federation|Volgograd, Russian Federation|Barcelona, Spain|Granada, Spain|Las Palmas De Gran Canaria, Spain|Madrid, Spain|Mallorca, Spain|Pamplona, Spain|Salamanca, Spain|Santander, Spain|Santiago De Compostela, Spain|Toledo, Spain|Valencia, Spain|Valladolid, Spain|Zaragoza, Spain|Blackpool, United Kingdom|Bournemouth, United Kingdom|Dundee, United Kingdom|Glasgow, United Kingdom|Kent, United Kingdom|Leeds, United Kingdom|Londonderry, United Kingdom|London, United Kingdom|Manchester, United Kingdom|Newcastle, United Kingdom|Nottingham, United Kingdom|Stoke On Trent, United Kingdom|Wolverhampton, United Kingdom Less <<
NCT04868838 Lupus Nephritis PHASE2 ACTIVE_NOT_RECRUITING 2025-07-26 Mayo Clinic in Rochester, Roch... More >>ester, Minnesota, 55905, United States Less <<
NCT03236428 Monoclonal Gammopathy|Smolderi... More >>ng Multiple Myeloma Less << PHASE2 ACTIVE_NOT_RECRUITING 2026-10-04 Pacific Cancer Care, Monterey,... More >> California, 93940, United States|Colorado Blood Cancer Institute, Denver, Colorado, 80218, United States|Massachusetts General Hospital, Boston, Massachusetts, 02214, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Insitute, Detroit, Michigan, 48201, United States Less <<
NCT03187262 Waldenstr?m Macroglobulinemia PHASE2 COMPLETED 2021-12-31 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02214, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|University of Washington, Seattle, Washington, 98109, United States Less <<
NCT04972942 T-cell Acute Lymphoblastic Leu... More >>kemia|T-Cell Acute Lymphoblastic Lymphoma Less << PHASE1 RECRUITING 2025-09-28 New York Medical College, Valh... More >>alla, New York, 10595, United States Less <<
NCT02413489 Lymphoma, Mantle-Cell|Lymphoma... More >>, Large B-Cell, Diffuse|Lymphoma, Follicular Less << PHASE2 TERMINATED 2017-06-01 Duarte, California, United Sta... More >>tes|Fountain Valley, California, United States|Jacksonville, Florida, United States|Pembroke Pines, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Louisville, Kentucky, United States|Baltimore, Maryland, United States|Rochester, Minnesota, United States|Omaha, Nebraska, United States|New Brunswick, New Jersey, United States|Pittsburgh, Pennsylvania, United States|Houston, Texas, United States|Seattle, Washington, United States|Adelaide, Australia|Box Hill, Australia|Melbourne, Australia|Brugge, Belgium|Gent, Belgium|Lille, France|Limoges Cedex, France|Nantes Cedex 01, France|Paris Cedex 10, France|Pessac, France|Pierre Benite, France|Rouen Cedex, France|Goyang si, Korea, Republic of|Seoul, Korea, Republic of|Amsterdam, Netherlands|Rotterdam, Netherlands|Utrecht, Netherlands|Ankara, Turkey|Atakum, Turkey|Istanbul, Turkey|Kocaeli, Turkey Less <<
NCT02816476 Amyloidosis PHASE2 COMPLETED 2025-10-20 CHU d'Angers, Angers, France|C... More >>HU de Caen, Caen, 14000, France|CHU de Limoges, Limoges, 87042, France|CHU de Lyon Sud, Lyon, France|APHP - Necker, Paris, France|APHP - Saint Antoine, Paris, France|APHP - Saint Louis, Paris, France|CHU Poitiers, Poitiers, France|CHU de Rennes, Rennes, France|Amyloidosis Research and Treatment Center, Pavia, Italy Less <<
NCT04024384 Multiple Myeloma PHASE2 WITHDRAWN 2025-07-24 Service d'hématologie clinique... More >> et thérapie cellulaire, Paris, 75012, France Less <<
NCT02927925 Lymphoma PHASE2 COMPLETED 2020-01-07 Cancer Hospital, Chinese Acade... More >>my of Medical Sciences, Beijing, 100021, China|Beijing Cancer Hospital, Beijing, 100142, China|Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China|1st Affiliated Hospital of Zhejiang University Medical College, Hangzhou, 310003, China|Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, 200025, China|Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong|National Cancer Center, Goyang-si, 10408, Korea, Republic of|Severance Hospital, Seoul, 03722, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, 06591, Korea, Republic of|Seoul National University Hospital, Seoul, 3080, Korea, Republic of|Asan Medical Center, Seoul, 5505, Korea, Republic of|Singapore General Hospital, Singapore, 169608, Singapore|National Cancer Centre Singapore, Singapore, 169610, Singapore|Changhua Christian Hospital, Changhua, 50006, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan Less <<
NCT03992170 Myeloma Multiple PHASE2 UNKNOWN 2022-12-31 Azienda Ospedaliera Universita... More >>ria Senese, Siena, 53100, Italy Less <<
NCT04251065 Refractory T-Cell Lymphoma|Rel... More >>apsed T-Cell Lymphoma Less << PHASE2 UNKNOWN 2022-11-15 IRCCS Istituto Tumori Giovanni... More >> Paolo II - U.O.C Ematologia, Bari, 70124, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia, Meldola, Forlì-Cesena, Italy|ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia, Milano, 20162, Italy|A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia, Palermo, 90146, Italy|Ospedale Guglielmo da Saliceto - U.O.Ematologia, Piacenza, 29121, Italy|A.O.U. Citta della Salute e della Scienza di Torino - Ematologia Universitaria, Torino, 10126, Italy|Trieste - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia, Trieste, 34121 Francesco, Italy Less <<
NCT04264884 - APPROVED_FOR_MARKETING - -
NCT05835726 Multiple Myeloma|Daratumumab|A... More >>utologous Stem Cell Transplantation|Leukapheresis Less << RECRUITING 2024-04-30 Fondazione Policlinico Univers... More >>itario A.Gemelli IRCCS, Rome, 00168, Italy Less <<
NCT04656951 Multiple Myeloma PHASE2 RECRUITING 2025-12-29 University of Cologne, Cologne... More >>, 50937, Germany Less <<
NCT05654506 Proliferative Glomerulonephrit... More >>is With Monoclonal IgG Deposits Less << PHASE2 RECRUITING 2025-08-26 Mayo Clinic, Jacksonville, Flo... More >>rida, 32224, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|University North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States Less <<
NCT05088330 Newly Diagnosed Multiple Myelo... More >>ma Less << UNKNOWN 2024-12-31 -
NCT04922723 Glioblastoma PHASE1|PHASE2 RECRUITING 2025-08-24 West Virginia University Cance... More >>r Institute Mary Babb Randolph Cancer Center, Morgantown, West Virginia, 26506, United States Less <<
NCT06549634 Acute Kidney Injury|Multiple M... More >>yeloma|Light Chain Nephropathy Less << RECRUITING 2025-10-26 Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States Less <<
 

Historical Records

Categories